These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2481792

  • 1. Prolonged survival of mice with myeloid leukemia by subcutaneous injection of recombinant human G-CSF.
    Bessho M, Susaki K, Hirashima K, Tamura M, Ono M.
    Leuk Res; 1989; 13(11):1001-7. PubMed ID: 2481792
    [Abstract] [Full Text] [Related]

  • 2. Suppression of the development of murine myeloid leukemia with granulocyte colony-stimulating factor by inducing apoptosis of leukemic cells.
    Bessho M, Yoshida S, Sakate K, Murohashi I, Jinnai I, Hirashima K.
    Leukemia; 1994 Jul; 8(7):1185-90. PubMed ID: 7518551
    [Abstract] [Full Text] [Related]

  • 3. Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line.
    Handa A, Kashimura T, Kawano N, Yamamoto A, Yoshida S, Jinnai I, Murohashi I, Bessho M, Hirashima K.
    Leukemia; 1997 Apr; 11 Suppl 3():387-8. PubMed ID: 9209400
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human granulocyte colony-stimulating factor on the growth potential of two murine myeloid leukemias.
    Kabaya K, Obuchi M, Kuwaki T, Shibuya K, Watanabe M, Nemoto K, Yoshida K, Kusaka M, Inoue T, Seki M.
    Leuk Res; 1996 Jan; 20(1):27-35. PubMed ID: 8632675
    [Abstract] [Full Text] [Related]

  • 5. A new cell line of murine myeloid leukemia with A-type phosphoglycerate kinase as marker isoenzyme.
    Kawai N, Bessho M, Hirashima K.
    Leuk Res; 1988 Jan; 12(11-12):911-6. PubMed ID: 3216672
    [Abstract] [Full Text] [Related]

  • 6. Reduction of the leukemogenic potential of malignant murine leukemic cells by in vivo treatment with recombinant human granulocyte colony-stimulating factor.
    Tamura M, Orita T, Oh-eda M, Hasegawa M, Nomura H, Maekawa T, Abe T, Ono M.
    Leuk Res; 1993 Jul; 17(7):593-600. PubMed ID: 7686992
    [Abstract] [Full Text] [Related]

  • 7. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H, Ishikawa J, Kitayama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F.
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [Abstract] [Full Text] [Related]

  • 8. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 9. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
    Tamura M, Nomura H, Ono M, Bessho M, Hirashima K.
    Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
    [Abstract] [Full Text] [Related]

  • 10. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
    Takahashi S, Okamoto SI, Shirafuji N, Ikebuchi K, Tani K, Shimane M, Matsudaira T, Irie S, Tsuruta T, Matsuishi E.
    Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P.
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice.
    Tanikawa S, Nose M, Aoki Y, Tsuneoka K, Shikita M, Nara N.
    Blood; 1990 Aug 01; 76(3):445-9. PubMed ID: 1696145
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K.
    J Immunol; 1991 Apr 15; 146(8):2639-47. PubMed ID: 1707914
    [Abstract] [Full Text] [Related]

  • 20. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S, Media JE, Nakeff A.
    Stem Cells; 1998 Apr 15; 16(2):144-51. PubMed ID: 9554039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.